Cutaneous lesions associated to multiple endocrine neoplasia syndrome type 1

被引:35
作者
Vidal, A. [1 ]
Iglesias, M. J. [1 ]
Fernandez, B. [3 ]
Fonseca, E. [3 ]
Cordido, F. [2 ]
机构
[1] Hosp Juan Canalejo, Serv Endocrinol & Nutr, La Coruna 15006, Spain
[2] Univ A Coruna, Dept Med, La Coruna, Spain
[3] Hosp Juan Canalejo, Serv Dermatol, La Coruna 15006, Spain
关键词
angiofibroma; collagenoma; lipoma; multiple endocrine neoplasia type 1;
D O I
10.1111/j.1468-3083.2008.02578.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Multiple endocrine neoplasia type 1 (MEN1) is a genetic disease that predisposes to endocrine tumour development. Some cutaneous lesions (angiofibromas, collagenomas, melanosis guttaca, lipomas, melanomas, 'cafe au lait macules') have been associated to this syndrome. We compare the prevalence of cutaneous lesion in affected patients with their non-carrier relatives. Patients and method We studied 9 patients with MEN1 and 20 non-carrier, first-degree relatives. Genetic screening was realized in all of them. Patients were examined by dermatologist, and biopsy was performed when necessary. Results Patients with MEN1 presented hyperparathyroidism (100%), neuroendocrine tumours of pancreas (66%) and pituitary adenomas (44%); their relatives were free of endocrine features of MEN1. The studied cutaneous lesions were more prevalent in affected patients than in non-carriers (55.5% vs. 25%; P = 0.029). Odds ratio of developing cutaneous lesions in MEN1 patients was 6.6 (95% confidence interval, 1.09-40.43). The frequency of angiofibromas was lower (22.2%) than the reported in other studies (43-88%), and we did not find any collagenoma. Conclusions MEN1 is associated to some cutaneous lesions and could be useful for detecting MEN1 carriers in an affected family. Cutaneous lesions should be assessed in MEN1 patients.
引用
收藏
页码:835 / 838
页数:4
相关论文
共 27 条
[11]   Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1 [J].
Gibril, F ;
Chen, YJ ;
Schrump, DS ;
Vortmeyer, A ;
Zhuang, ZP ;
Lubensky, IA ;
Reynolds, JC ;
Louie, A ;
Entsuah, LK ;
Huang, K ;
Asgharian, B ;
Jensen, RT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (03) :1066-1081
[12]   Hibernomas are characterized by homozygous deletions in the multiple endocrine neoplasia type I region -: Metaphase fluorescence in situ hybridization reveals complex rearrangements not detected by conventional cytogenetics [J].
Gisselsson, D ;
Höglund, M ;
Mertens, F ;
Dal Cin, P ;
Mandahl, N .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (01) :61-66
[13]   Germline MEN1 mutations in sixteen Japanese families with multiple endocrine neoplasia type 1 (MEN1) [J].
Hai, N ;
Aoki, N ;
Matsuda, A ;
Mori, T ;
Kosugi, S .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1999, 141 (05) :475-480
[14]  
Komminoth P, 1998, J INTERN MED, V243, P455
[15]   Genotype-phenotype analysis in multiple endocrine neoplasia type 1 [J].
Kouvaraki, MA ;
Lee, JE ;
Shapiro, SE ;
Gagel, RF ;
Sherman, SI ;
Sellin, RV ;
Cote, GJ ;
Evans, DB .
ARCHIVES OF SURGERY, 2002, 137 (06) :641-647
[16]   Identification of the multiple endocrine neoplasia type 1 (MEN1) gene [J].
Lemmens, I ;
VandeVen, WJM ;
Kas, K ;
Zhang, CX ;
Giraud, S ;
Wautot, V ;
Buisson, N ;
DeWitte, K ;
Salandre, J ;
Lenoir, G ;
Pugeat, M ;
Calender, A ;
Parente, F ;
Quincey, D ;
Gaudray, P ;
DeWit, MJ ;
Lips, CJM ;
Hoppener, JWM ;
Khodaei, S ;
Grant, AL ;
Weber, G ;
Kytola, S ;
Teh, BT ;
Farnebo, F ;
Phelan, C ;
Hayward, N ;
Larsson, C ;
Pannett, AAJ ;
Forbes, SA ;
Bassett, JHD ;
Thakker, RV .
HUMAN MOLECULAR GENETICS, 1997, 6 (07) :1177-1183
[17]   Multiple endocrine neoplasia type 1: Clinical and genetic topics [J].
Marx, S ;
Spiegel, AM ;
Skarulis, MC ;
Doppman, JL ;
Collins, FS ;
Liotta, LA .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (06) :484-494
[18]  
Nord B, 2000, INT J CANCER, V87, P463, DOI 10.1002/1097-0215(20000815)87:4<463::AID-IJC1>3.0.CO
[19]  
2-8
[20]  
Öberg K, 1998, J INTERN MED, V243, P471